Skip to content
Trial Eligibility
Menu

Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer

NCT07076147

This study is recruiting at 2 US sites in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This study assesses breast cancer screening adherence for women at moderately increased risk for developing breast cancer based on gene mutation status or empiric risk model estimates. It also seeks to determine facilitators and barriers to screening.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Breast Carcinoma

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
30 to 75 years
Sex
Female
Healthy volunteers
Accepted
Sponsor
University of Southern California
Last updated on ClinicalTrials.gov
June 1, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 2

  • Los Angeles General Medical Center · Los Angeles, CA
  • USC / Norris Comprehensive Cancer Center · Los Angeles, CA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.